Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8967 | 1132 | 30.0 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LYMPHOBLASTIC LYMPHOMA | Author keyword | 36 | 41% | 6% | 69 |
2 | BURKITTS LYMPHOMA | Author keyword | 29 | 23% | 10% | 110 |
3 | BURKITT LYMPHOMA | Author keyword | 28 | 25% | 9% | 100 |
4 | PEDIATRIC FOLLICULAR LYMPHOMA | Author keyword | 9 | 83% | 0% | 5 |
5 | NHL BFM STUDY | Address | 7 | 40% | 1% | 14 |
6 | BURKITT LIKE LYMPHOMA | Author keyword | 7 | 53% | 1% | 9 |
7 | PEDIATRIC NON HODGKINS LYMPHOMA | Author keyword | 6 | 80% | 0% | 4 |
8 | ENDEMIC BURKITT LYMPHOMA | Author keyword | 6 | 71% | 0% | 5 |
9 | SMALL NONCLEAVED CELL LYMPHOMA | Author keyword | 6 | 71% | 0% | 5 |
10 | BERKITTS LYMPHOMA | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FRANKFURT MUNSTER GROUP | 64 | 61% | 6% | 69 |
2 | PEDIATRIC ONCOLOGY SOCIETY | 56 | 81% | 3% | 34 |
3 | ONCOLOGY SOCIETY | 27 | 92% | 1% | 11 |
4 | NONCLEAVED CELL LYMPHOMA | 26 | 59% | 3% | 29 |
5 | MULTIAGENT CHEMOTHERAPY | 21 | 52% | 3% | 29 |
6 | LSA2 L2 | 21 | 85% | 1% | 11 |
7 | CODOX M IVAC | 15 | 62% | 1% | 16 |
8 | NHL BFM 90 | 15 | 88% | 1% | 7 |
9 | PEDIATRIQUE LMB89 PROTOCOL | 12 | 86% | 1% | 6 |
10 | SMALL NONCLEAVED CELL | 11 | 60% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Adult Burkitt leukemia and lymphoma | 2004 | 198 | 74 | 35% |
Lymphoblastic lymphoma | 2011 | 22 | 91 | 48% |
Burkitt lymphoma in adults | 2012 | 15 | 44 | 57% |
Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma | 2013 | 5 | 9 | 78% |
Adult Lymphoblastic Lymphoma | 2012 | 7 | 36 | 81% |
The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma | 2011 | 16 | 42 | 50% |
Non-Hodgkin's Lymphomas | 2010 | 69 | 117 | 18% |
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas | 1998 | 32 | 19 | 74% |
Burkitt lymphoma: the role of Epstein-Barr virus revisited | 2012 | 11 | 44 | 57% |
Co-infections, inflammation and oncogenesis: Future directions for EBV research | 2014 | 13 | 195 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NHL BFM STUDY | 7 | 40% | 1.2% | 14 |
2 | LYMPHNODE REGISTRY | 4 | 67% | 0.4% | 4 |
3 | SOC GERMAN PATHOL | 3 | 100% | 0.3% | 3 |
4 | MED OMAHA | 2 | 67% | 0.2% | 2 |
5 | NONHODGKIN LYMPHOMA BERLIN FRANKFURT MUNSTER GRP | 2 | 67% | 0.2% | 2 |
6 | CLIN ONCOEMATOL PEDIAT | 2 | 16% | 0.8% | 9 |
7 | UKCCSG | 2 | 26% | 0.4% | 5 |
8 | GLOUCESTERSHIRE HOSP | 1 | 38% | 0.3% | 3 |
9 | NOGUCHI MEM | 1 | 50% | 0.2% | 2 |
10 | IST RIC PEDIAT | 1 | 33% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000183120 | INT OUTREACH PROGRAM//DUTCH CANC//DOCTOR DOCTOR PROGRAM 2 |
2 | 0.0000134785 | DIFFUSE LARGE B CELL LYMPHOMA//PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA//GRAY ZONE LYMPHOMA |
3 | 0.0000109910 | FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA |
4 | 0.0000107190 | TESTICULAR LYMPHOMA//PRIMARY TESTICULAR LYMPHOMA//OVARIAN LYMPHOMA |
5 | 0.0000102069 | AIDS RELATED LYMPHOMA//NON AIDS DEFINING CANCER//NON AIDS DEFINING CANCERS |
6 | 0.0000101685 | WALDEYERS RING//LARYNGEAL LYMPHOMA//TONSILLAR LYMPHOMA |
7 | 0.0000100058 | TUMOR LYSIS SYNDROME//RASBURICASE//ACUTE TUMOR LYSIS SYNDROME |
8 | 0.0000093039 | TONSIL NEOPLASM//TONSILLAR METASTASIS//TONSIL PATHOLOGY |
9 | 0.0000091155 | ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//NPM ALK |
10 | 0.0000080735 | PRIMARY BONE LYMPHOMA//OSTEOLYMPHOMA//BONE LYMPHOMA |